No other market segment is growing as fast as medicines containing highly potent active pharmaceutical ingredients (HPAPI). Whether special drugs for individual medicine or generics: drug production under containment is quickly becoming the new standard worldwide. Pharmaceutical companies are currently adjusting their manufacturing infrastructure and production processes with agility and flexibility never seen before.
Are you prepared for this new reality?
Join our first digital Containment Circle on May 27, 2021 and get advice from leading industry experts on how to successfully build and run a world-class contained OSD production.
